Regular Article
You have free access to this content
Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes
Article first published online: 20 MAR 2009
DOI: 10.1111/j.1440-1819.2009.01937.x
© 2009 The Authors. Journal compilation © 2009 Japanese Society of Psychiatry and Neurology
Additional Information
How to Cite
Chou, W.-J., Chou, M.-C., Tzang, R.-F., Hsu, Y.-C., Gau, S. S.-F., Chen, S.-J., Wu, Y.-Y., Huang, Y.-F., Liang, H.-Y. and Cheng, H. (2009), Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Psychiatry and Clinical Neurosciences, 63: 167–175. doi: 10.1111/j.1440-1819.2009.01937.x
Publication History
- Issue published online: 20 MAR 2009
- Article first published online: 20 MAR 2009
- Received 21 April 2008; revised 2 December 2008; accepted 8 December 2008.
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder, NeuroImage: Clinical, 2013, 2, 366
- 2, , , , , , Psychometric properties of the Chinese version of Strength and Difficulties Questionnaire, Comprehensive Psychiatry, 2013,
- 3, , , , Separate and overlapping relationships of inattention and hyperactivity/impulsivity in children and adolescents with attention-deficit/hyperactivity disorder, ADHD Attention Deficit and Hyperactivity Disorders, 2013, 5, 1, 9
- 4, , , , , , Adherence with Electronic Monitoring and Symptoms in Children with Attention Deficit Hyperactivity Disorder, Psychiatry Investigation, 2012, 9, 3, 263
- 5, Factors related to Medication Adherence according to Severity of Attention Deficit Hyperactivity Disorder in Children, Journal of Korean Academy of Psychiatric and Mental Health Nursing, 2012, 21, 4, 321
- You have free access to this content6, , , , , , , , , , , , , , , , , , Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit–hyperactivity disorder , Psychiatry and Clinical Neurosciences, 2012, 66, 1Direct Link:
- 7, , , , , , , , , , , , , , , , , , , , Remission in Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder via an Effective and Tolerable Titration Scheme for Osmotic Release Oral System Methylphenidate, Journal of Child and Adolescent Psychopharmacology, 2012, 22, 3, 215
- 8
- 9, , Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence, European Child & Adolescent Psychiatry, 2011, 20, S2, 235
- 10, , , , , , , Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?, Child and Adolescent Psychiatry and Mental Health, 2011, 5, 1, 26
- You have free access to this content11, , Editorial, Psychiatry and Clinical Neurosciences, 2010, 64, 1Direct Link:
- 12, , Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants, European Child & Adolescent Psychiatry, 2010, 19, 4, 325

1440-1819/asset/olbannerleft.gif?v=1&s=53aa57299a73f1cea88ed36d923a25e042c23538)
